What does Shattuck Labs, Inc. do?
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment…
What is Shattuck Labs, Inc.'s P/E and P/B ratio?
Shattuck Labs, Inc. has a P/E ratio of -11.9 and a P/B ratio of 2.66.
What is Shattuck Labs, Inc.'s debt-to-equity ratio?
Shattuck Labs, Inc. has a debt-to-equity ratio of 0.01.
How much does Shattuck Labs, Inc. owe compared with what it owns?
Shattuck Labs, Inc. owes $0.04 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Shattuck Labs, Inc.'s Positivity rank?
Shattuck Labs, Inc. is ranked #4,447 of 6,774 companies globally and #2,224 of 4,000 in United States on PositoAI, with a Positivity Score of 19,446.
Does Shattuck Labs, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Shattuck Labs, Inc..
Where can I read the latest news about Shattuck Labs, Inc.?
Recent headlines about Shattuck Labs, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Shattuck Labs, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Shattuck Labs, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.